Company intelligence / Profile preview

Clionsky Neuro Systems

Springfield, Massachusetts, United Statesbraindoc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Clionsky Neuro Systems has developed proprietary computerized diagnostic tools for assessing cognitive function. Their Memory Orientation Screening Test ("MOST") provides a validated numerical score to track cognitive status over time. The company supports clinicians in early identification of memory loss to enable timely intervention. They have published clinical research validating their approach[3][4].

Therapeutic areas: OncologyPulmonologyRare DiseasesPsychiatryCardiovascularNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Strategic relationships with industry leaders in pharmaceuticals, imaging, benefits management, insurance companies, large healthcare organizations/practice groups

Beyond the preview

Go deeper on Clionsky Neuro Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clionsky Neuro Systems.

Explore the full profile